Zhiheng Zhang

Harbin, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Correction to: N‑Acetylcysteine Mitigates Ketamine Neurotoxicity in Young Rats by Modulating ROS‑Mediated Pyroptosis and Ferroptosis.

Correction to: N‑Acetylcysteine Mitigates Ketamine Neurotoxicity in Young Rats by Modulating ROS‑Mediated Pyroptosis and Ferroptosis.

Journal: Molecular neurobiology
Published: June 09, 2025

N-Acetylcysteine Mitigates Ketamine Neurotoxicity in Young Rats by Modulating ROS-Mediated Pyroptosis and Ferroptosis.

N-Acetylcysteine Mitigates Ketamine Neurotoxicity in Young Rats by Modulating ROS-Mediated Pyroptosis and Ferroptosis.

Journal: Molecular neurobiology
Published: November 20, 2024

Ganglioside GM1 Alleviates Propofol-Induced Pyroptosis in the Hippocampus of Developing Rats via the PI3K/AKT/NF-κB Signaling Cascade.

Ganglioside GM1 Alleviates Propofol-Induced Pyroptosis in the Hippocampus of Developing Rats via the PI3K/AKT/NF-κB Signaling Cascade.

Journal: International journal of molecular sciences
Published: November 05, 2024

Preparation of β-Cyclodextrin(CD)/Flavour CD Powder and Its Application on Flavour Improvement of Regular Coffee.

Preparation of β-Cyclodextrin(CD)/Flavour CD Powder and Its Application on Flavour Improvement of Regular Coffee.

Journal: Foods (Basel, Switzerland)
Published: June 29, 2024

Carbon emission quantification analysis of excavation engineering under road transport conditions.

Carbon emission quantification analysis of excavation engineering under road transport conditions.

Journal: PloS one
Published: May 13, 2024

Correction to: Protective Effect of GM1 Attenuates Hippocampus and Cortex Apoptosis After Ketamine Exposure in Neonatal Rat via PI3K/AKT/GSK3β Pathway.

Correction to: Protective Effect of GM1 Attenuates Hippocampus and Cortex Apoptosis After Ketamine Exposure in Neonatal Rat via PI3K/AKT/GSK3β Pathway.

Journal: Molecular neurobiology
Published: April 09, 2024

GPX4 Inhibition Contributes to NLRP3-Mediated Pyroptosis and Cognitive Impairment in Ketamine-Exposed Neonatal Rats.

GPX4 Inhibition Contributes to NLRP3-Mediated Pyroptosis and Cognitive Impairment in Ketamine-Exposed Neonatal Rats.

Journal: Molecular neurobiology
Published: March 03, 2024

Downregulation of the NLRP3/Caspse-1 Pathway Ameliorates Ketamine-Induced Liver Injury and Inflammation in Developing Rats.

Downregulation of the NLRP3/Caspse-1 Pathway Ameliorates Ketamine-Induced Liver Injury and Inflammation in Developing Rats.

Journal: Molecules (Basel, Switzerland)
Published: April 06, 2022

Inhibition of the NLRP3/caspase-1 signaling cascades ameliorates ketamine-induced renal injury and pyroptosis in neonatal rats.

Inhibition of the NLRP3/caspase-1 signaling cascades ameliorates ketamine-induced renal injury and pyroptosis in neonatal rats.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 15, 2022

Comparison of cardiorespiratory and anesthetic effects of ketamine-midazolam-xylazine-sufentanil and tiletamine-zolazepam-xylazine in miniature pigs.

Comparison of cardiorespiratory and anesthetic effects of ketamine-midazolam-xylazine-sufentanil and tiletamine-zolazepam-xylazine in miniature pigs.

Journal: PloS one
Published: February 23, 2022

Activation of adenosine A3 receptor attenuates progression of osteoarthritis through inhibiting the NLRP3/caspase-1/GSDMD induced signalling.

Activation of adenosine A3 receptor attenuates progression of osteoarthritis through inhibiting the NLRP3/caspase-1/GSDMD induced signalling.

Journal: Journal of cellular and molecular medicine
Published: December 07, 2021

CF101 alleviates OA progression and inhibits the inflammatory process via the AMP/ATP/AMPK/mTOR axis.

CF101 alleviates OA progression and inhibits the inflammatory process via the AMP/ATP/AMPK/mTOR axis.

Journal: Bone
Published: September 29, 2021
Showing 1-12 of 23

Last Updated: 09/26/2026